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Illustrated operative management of spontaneous
bleeding and compartment syndrome of the
lower extremity in a patient with acquired
hemophilia A: a case report
Thorsten Jentzsch1*, Brigitte Brand-Staufer2, Frank P Schäfer1, Guido A Wanner1 and Hans-Peter Simmen1
Abstract
Introduction: Spontaneous bleeding resulting in compartment syndrome at the lower adult leg due to acquired
hemophilia A is rare. There are no reports on operative management of this entity.
Case presentation: We present a case of atraumatic compartment syndrome of the lower leg due to acquired
factor VIII deficiency, in an 83-year-old Caucasian man of European descent. He was treated surgically with a long
and complicated postoperative course after presenting to a community hospital with a 2-day history of increasing
pain and swelling in his left lower leg without a previous history of trauma.
Conclusions: Awareness, prompt diagnosis and effective treatment of compartment syndrome caused by a rare
bleeding disorder, which is usually acquired by the elderly, is essential and may spare a patient from surgery or
even limb loss, if early administration of recombinant factor VIIa is effective. The course of disease in a patient with
operative management of spontaneous bleeding, compartment syndrome and acquired hemophilia A may be
prolonged. However, an interdisciplinary approach with meticulous surgical treatment and bleeding management
with recombinant factor VIIa as well as inhibitor eradication by immunosuppressive treatment can be successful
and expensive.
Keywords: Acquired hemophilia A, Compartment syndrome, Factor VIII deficiency, Fasciotomy, Lower extremity,
Operative management
Introduction
Spontaneous bleeding and compartment syndrome due
to acquired hemophilia A, which is defined by factor
VIII deficiency caused by an inhibitory antibody to fac-
tor VIII, is extremely rare [1]. This is in contrast to the
more well-known and rather common compartment
syndrome due to traumatic etiologies, of which the ma-
jority may be attributed to fractures [2]. Only a few case
reports have focused on compartment syndrome in the
realm of acquired hemophilia A in the adult [3-5] and
pediatric population [6-11], respectively. Almost all of
these case reports addressed problems in the upper
extremities [4-7] or described conservative treatment
[3,5]. There is a lack of studies [6,7] on operative man-
agement of compartment syndrome due to acquired
hemophilia A and none describe this entity on the lower
extremities. Therefore, we present a case of atraumatic
compartment syndrome of the lower leg due to acquired
hemophilia A, in an elderly Caucasian man who was
treated surgically with a long and complicated postoper-
ative course.
Case presentation
An 83-year-old Caucasian man of European descent pre-
sented to a community hospital with a 2-day history of
increasing pain and swelling in his left lower leg without
a previous history of trauma. His relevant past medical
history included fasciotomy of an atraumatic compartment
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syndrome of his left thigh 2 months ago, traumatic hemar-
throsis of his right knee half a year ago and a 2-year course
of low-dose steroid therapy for polymyalgia. Furthermore,
he had hypertensive cardiomyopathy, permanent atrial fib-
rillation, benign prostate hyperplasia, presbyacusis, and a
history of surgery for patellar tendon rupture 1 year ago.
Aside from prednisolone 5mg/day, he took nebivolol
2.5mg/day, torasemide 10mg/day and tamsulosin 0.4mg/
day. Warfarin had been stopped 2 months ago after his
compartment syndrome of the thigh.
During physical examination, he had pain at rest, to
palpation and with passive stretching of the foot (Nu-
meric Rating Scale 4 to 5) at his left lower leg. Marked
swelling with emerging tension blisters was found at his
proximal anterior tibia. His peripheral pulses were palp-
able and his neurologic status was intact. There were
no systemic signs of disease. Ultrasound revealed a
hematoma, 6×3×2cm, in the anterior tibial compart-
ment, but no evidence of vessel pathology or deep vein
thrombosis. Compartment pressure of the anterior tibial
compartment was measured with the help of a pressure
monitoring device and was markedly elevated. Labora-
tory findings included an elevated C-reactive protein of
94mg/L (normal <5mg/L), decreased hemoglobin of
86g/L (normal 125 to 172g/L), decreased hematocrit of
0.28L/L (normal 0.37 to 0.49L/L) and prothrombin time
(PT) of 87% (normal 70 to 100%). Activated partial
thromboplastin time (aPTT; normal 24 to 36 seconds)
was not measured because it was falsely not deemed
relevant or simply forgotten at that time.
The diagnosis of compartment syndrome was made
and the patient underwent immediate lateral fasciotomy
with a limited incision of approximately 5cm of the an-
terior tibial compartment by a rather small skin incision
and subcutaneous fascia release as described by Mubarak
and Owen [12] (Table 1 outlines the course of disease).
The anterior tibialis muscles protruded instantly and were
still vital. The wound was left open and covered with
dressings. Two days later, secondary hemorrhage and foot
drop (M3, active movement against gravity) developed.
Thus, he was taken to the operating room again and a
hematoma within the anterior tibial compartment was
evacuated. Postoperatively, his foot drop mildly improved.
Again, 2 days later, another secondary hematoma occurred
and he was transferred to a larger regional hospital in
order to treat his condition, with its peculiar laboratory
findings and uncontrollable bleeding, in the realm of an
interdisciplinary approach. The lateral fasciotomy wound
was lengthened [13]. Furthermore, his aPTT was mea-
sured and found to be elevated, which prompted further
hematologic evaluation. On the fifth postoperative day,
diagnosis of acquired hemophilia A was finally made by a
hematology consultant. Due to massive unstoppable
bleeding of approximately 0.5L/hour accompanied by a
fall in hematocrit from 29% to 19.5%, despite the adminis-
tration of four units of red blood cells, recombinant factor
Table 1 Course of disease
Day(s) after
diagnosis
Clinical symptoms Laboratory (factor VIII, Bethesda test,
activated partial thromboplastin time)
Therapy
0 Compartment syndrome Minimally invasive lateral fasciotomy
2 Secondary hemorrhage and foot drop
(M3, active movement against gravity)
Hematoma evacuation
4 Secondary hemorrhage Recognition of prolonged activated partial
thromboplastin time
Lateral fasciotomy elongation
5 Diagnosis of acquired hemophilia A Recombinant factor VIIa and corticosteroids
6, 7 3%, 3 Bethesda units, 76 seconds Vacuum-assisted closure (change)
9, 11 Secondary hemorrhage Polyvinyl alcohol foam, jetting hose and
absorbable dressing
15 Secondary hemorrhage 3%, 8 Bethesda units, 40 seconds Vacuum-assisted closure polyvinyl alcohol
foam, jetting hose and absorbable dressing
17–28 9–33%, 4 Bethesda units, 26–35 seconds Polyvinyl alcohol foam, jetting hose and
absorbable dressing changes
31 41% Vacuum-assisted closure
35 normal Vacuum-assisted closure change
43 normal Split-thickness skin graft
46–106 Delayed wound healing normal Open wound therapy with AQUACEL® and
Mepitel®
107 normal Second split-thickness skin graft
108–170 Healed wound normal Dismission from traumatologic treatment
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VIIa (rFVIIa) was used as a single bleeding control agent
and corticosteroids (1mg/kg body weight) were increased
for inhibitor eradication. Of note, no other blood products
or factor replacements were administered. In our hospital,
we also do not administer factor VIII inhibitor bypass ac-
tivity (FEIBA) routinely in acquired hemophilia A, but re-
serve this treatment for refractory hereditary cases. With
this drug therapy in place and the assumption that his un-
controlled bleeding had been controlled, vacuum-assisted
closure (VAC) therapy was instigated. VAC therapy repre-
sents the regional standard therapy for most open wounds
and even though it may monitor the amount of bleeding,
it does not provide visual control. However, secondary
hemorrhage occurred again and the patient was trans-
ferred to a university hospital.
In order to halt the uncontrollable bleeding, the
wound was covered with a special dressing with polyvi-
nyl alcohol (PVA) foam, a jetting hose through which
the wound was kept moist and a big bulky absorbable
dressing (Figures 1a, 1b). On day 15, implementation of
VAC therapy failed again and uncontrollable bleeding
led to further therapy with the special dressing men-
tioned above (Figures 2a and 3). By this time, the patient
had received at least seven units of red blood cells and
almost 20 administrations of NovoSeven® (rFVIIa), usu-
ally in the dose of 7mg each. No other blood products
were used except for 1g of tranexamic acid intraopera-
tively on his arrival at the university hospital. At that
point his factor VIII was still 3%. For the next 2 weeks,
dressing changes were undertaken at regular intervals of
approximately 3 days. Administration of rFVIIa at regu-
lar intervals, at least once a day just shortly before
dressing changes was continued. His factor VIII started
to rise slowly, beginning on day 17 with 9%. After
4 weeks, his factor VIII had risen to 41% and VAC ther-
apy could be applied again in order to condition the
wound for definite closure (Figure 2b). After another
VAC change, and rise of factor VIII to 88%, a split-
thickness skin graft was carried out 1.5 months after the
first fasciotomy. At this time, rFVIIa support was no
longer necessary. After leaving a VAC on top of the
split-thickness skin graft for 5 days, mild delayed wound
healing was observed in the anterior middle and poster-
ior distal parts of the wound (Figure 4a). This was
treated with AQUACEL® (primary wound dressing) and
Mepitel® (wound contact layer), (wound contact layer),
while the rest of the wound was dressed with dry pad-
ding. In the meantime, factor VIII had increased >100%
and corticosteroid therapy could be reduced in a step-
wise fashion approximately twice a month. After dis-
charging the patient into a rehabilitation clinic 2 months
postoperatively, he was frequently seen in our out-
patient clinic (Figure 4b). After 3.5 months, small parts
of the wound had still not healed (Figure 4c), and a
split-thickness skin graft was carried out for a second
time (Figure 5a to 5c) Afterward, wound healing went
Figure 1 Special wound dressings. a. Wound dressing on lower
leg with PVA foam and jetting hose. b. Bulky absorbable wound
dressing on lower leg.
Figure 2 Uncontrollable bleeding. a. Wound with uncontrollable
bleeding on lower leg 2 weeks after diagnosis. b. Wound with
controlled bleeding on lower leg 1 month after diagnosis.
Figure 3 Secondary hemorrhage with vacuum-assisted closure
therapy on lower leg.
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slowly, but finally succeeded approximately 5 months
after his initial presentation while his factor VIII
remained normal and prednisone was stopped 5 months
after diagnosis (Figure 6). He had 5 out of 5 muscle
strength globally, but needed to ambulate with crutches
after being confined to bed rest for a long time.
Unfortunately, the patient was hospitalized again after
4.5 months. This time, he had developed a spontaneous
hematoma in his left iliopsoas muscle. It was not due to
a relapse of acquired anti-factor VIII deficiency, but riv-
aroxaban, which had been administered for intermittent
atrial fibrillation. From that point, oral anticoagulants
were stopped and he only received low-molecular-
weight heparins daily while immobilized. Unfortunately,
he also developed subacute cholangitis, which was sus-
pected due to icterus and increased cholestasis/liver pa-
rameters followed by an ultrasound and a computed
tomography scan of the abdomen as well as a magnetic
resonance cholangiopancreatography and finally con-
firmed by a liver biopsy. He is scheduled for a rehabilita-
tion program in order to regain normal ambulation
without crutches upon his discharge from our hospital.
Discussion
Acquired hemophilia is a rare hemorrhagic disorder and
occurs at a rate of approximately one person per million
each year [8,14-19]. It mainly affects the elderly without
gender preference. Spontaneous remission may occur in
up to one-third of patients [20]. Nonetheless, the mor-
tality rate has been reported to be as high as 22% in a
survey by Green and Lechner [8]. Acquired hemophilia
is caused by formation of an inhibitory antibody directed
against coagulation factor VIII. Its origin is idiopathic in
approximately half of cases (46 to 65%), but may be re-
lated to other medical conditions, such as autoimmune
disorders in about 18%, malignancies (7 to 15%) or the
post-partum period (7 to 11%) [15,21]. It may lead to se-
vere and potentially life-threatening bleeding once factor
VIII decreases <25%. Suspicion usually arises with un-
controllable bleeding after a surgical procedure or spon-
taneous bleeding in patients with no history of a
bleeding disorder [22]. The diagnosis should be sus-
pected with prolonged aPTT. A prolonged aPTT may be
Figure 4 Delayed wound healing. a. Delayed wound healing in
the anterior part of the split-skin graft on the lower leg 2 weeks after
split-skin grafting and 2 months after diagnosis. b. Wound on lower
leg 1.5 months after split-skin grafting and 3 months after diagnosis.
c. Wound on lower leg 2 months after split-skin grafting and 3.5 months
after diagnosis.
Figure 5 Second split-thickness skin graft. a. Delayed wound
healing after 3.5 months. b. Intraoperative wound after
debridement after 3.5 months. c. Second split-thickness skin graft
after 3.5 months. Figure 6 Healed wound on lower leg after 5 months.
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attributable to several causes, such as coagulation factor
deficiencies, lupus anticoagulant or heparin therapy and
differentiation is achieved by mixing tests, where the
plasma of the patient is mixed with normal plasma [23].
Initially normal, but increased aPTT after 2 hours of in-
cubation is suggestive of autoantibodies to factor VIII.
Yet, the PT remains normal. Mixing studies of aPTT can
be performed in most laboratories and support the sus-
picion of acquired hemophilia. More specifically, factor
VIII can be quantified and is usually decreased <50%.
Afterward, the antibody is assessed with the Bethesda
assay, which measures residual factor VIII in the plasma
of the patient after incubation with plasma from a
healthy person [24,25]. Therapeutic approaches include
bleeding control with a so-called bypassing agent, either
rFVIIa (NovoSeven®) or activated prothrombin complex
(FEIBA®) and antibody eradication with prednisone alone
or in combination with other immunosuppressives, such
as cyclophosphamide or rituximab. RFVIIa activates fac-
tor X via the extrinsic system in the absence of factor
VIII. Thus, thrombin and fibrin are activated and blood
clotting follows [26]. However, rFVIIa has a short half-
life of only 2 hours and requires frequent administra-
tions [27]. Prednisone is the classic first-line therapy for
antibody eradication and is effective in about 30 to 75%
of cases [14]. Cyclophosphamide has been shown to in-
crease the overall response rate, but is usually not used
initially due to its severe side effects, particularly infec-
tious complications in the cohort of old to very old pa-
tients. In addition, transfusions are necessary in almost
90% of cases.
Compartment syndrome is rare with an incidence of
three per 100,000 people [2]. Men are more commonly
affected. The origin is a rise in pressure inside a muscle
compartment [28]. Compartment syndrome is often
caused by hematoma formation due to fractures. There
are four muscle compartments in the calf. The anterior
compartment is most commonly affected, it contains the
dorsiflexors of the foot and the deep peroneal nerve; the
lateral compartment contains the foot elevators, part of
the plantar flexors and the superficial fibular nerve. The
posterior compartment is subdivided into a superficial
and deep compartment; it contains the plantar flexors
and the tibial nerve. Failure to recognize compartment
syndrome or delay in treatment may lead to serious dis-
ability. Compartment syndrome is a clinical diagnosis.
Progressive nerve symptoms, such as paresthesia, are the
first symptoms and usually arise within 30 minutes. The
remaining classically described “six Ps” – pain, pallor,
pulselessness, pressure, poikilothermia and paralysis –
often arise too late, because irreversible tissue damage
may begin within 3 hours, as described in a cohort ana-
lysis of 76 patients by Vaillancourt et al. [29]. Compart-
ment pressures can be measured non-invasively or
invasively. Pressures >30mmHg have been accepted as
an indication for fasciotomy in order to avoid irrevers-
ible tissue damage [30]. Fasciotomy incisions should be
large enough to sufficiently decompress affected com-
partments and in the case of the calf measure about
15cm. The approach is either through a single lateral
parafibular incision or combined anterolateral and pos-
teromedial incisions; the latter is more common. Skin
closure should not be performed until the swelling has
reached its peak. As described in a review by Shadgan
et al. [31], there are several options, such as primary
closure with skin reapproximation, split-thickness skin
grafting, dermatotraction with staples, vessel loops
and vacuum-assisted wound closure. We usually use
vacuum-assisted wound closure for wound conditioning
before split-thickness skin grafting. As summarized by
Holle et al. [32], it functions by stabilizing tissue, giving
protection against infections, improving blood circula-
tion within tissues, and induction of wound healing.
McCallon et al. [33] reported that vacuum-assisted
wound closure was able to decrease the volume of the
wound better than normal wound dressings (28 versus
10%) and also led to faster wound closure (23 versus
43 days). In our case, vacuum-assisted wound closure
failed in the initial phase because of the uncontrollable
bleeding, but was effective once bleeding was controlled.
As mentioned by Ojike et al. [34], a split-thickness skin
graft is usually used to cover large wounds after com-
partment syndrome. Schneider et al. [35] attributed
wound healing to the equal pressure distribution on the
skin graft in 98% of a total of 100 patients, who were
treated with vacuum-assisted wound closure on top of
the skin graft for a couple of days.
From an economic standpoint, rFVIIa may be expen-
sive for health care providers since a single dose for an
average adult patient costs approximately US$7000. Due
to the short half-life, there is always a need for more
than one administration daily for a course of a couple of
weeks. Thus, expenses up to a hundred thousand may
arise quickly. In our case, rFVIIa was given 49 times,
which added up to approximately $340,000. However,
the hospital received approximately $60,000 for the
diagnosis-related group. Thus, there is a deficit of
$280,000, which has to be paid by the treating hospital.
However, these costs are comparable to other drugs for
rare diseases, such as $250,000 a year for lomitapide for
homozygous familial hypercholesterolemia or $295,000
per year for teduglutide for short bowel syndrome [36].
A new drug, ibrutinib, for chronic lymphatic leukemia
will also cost $130,000 per year [37]. Therefore, it is rea-
sonable to transfer these patients with rare and difficult-
to-treat medical conditions to hospitals with a higher
level of care. Importantly, treatment with rFVIIa needs
to be performed adequately and, as in our case, only be
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initiated once other factors have been substituted. It is
important to point out that the two treatment priorities
of acquired hemophilia A are to arrest the acute bleed-
ing with rFVIIa and to eradicate the factor VIII autoanti-
body with corticosteroids [38].
Our case report points out several important facts. We
agree with Ilyas et al. [4], who mentioned that atraumatic
compartment syndromes due to bleeding disorders de-
serve special attention and are easily overlooked. Early
suspicion, investigation and confirmation of an acquired
bleeding disorder are very important in order to avoid in-
vasive investigations or surgeries without adequate sup-
port of coagulation. Usually, compartment syndrome is a
surgical emergency because irreversible tissue injury be-
gins approximately 6 hours after onset and may lead to
tissue necrosis, functional impairment and renal failure
[39]. It is only within this very short time window that it
may be feasible to perform serial measurements of com-
partment pressure and postpone surgery in patients with
elevated compartment pressures and hemophilia A be-
cause uncontrollable bleeding may arise during surgery,
especially with factor VIII levels <50% [39]. During the
first 6 hours, first-line treatment consists of bleeding con-
trol with bypassing agents depending on the underlying
acquired disorder. But if compartment pressures remain
elevated ≥30mmHg and do not normalize within 2 hours,
fasciotomy is needed [40]. Unfortunately, diagnosis of
compartment syndrome in the absence of trauma is com-
monly delayed and made after 6 hours of onset, therefore
requiring immediate fasciotomy [11]. Once surgical man-
agement is instigated, the course of disease in a patient
with spontaneous bleeding, compartment syndrome and
acquired hemophilia A may be prolonged, complicated,
costly and requires a close collaboration between surgeons
and hematologists.
Conclusions
Awareness, prompt diagnosis and effective treatment of
compartment syndrome caused by a rare bleeding dis-
order, which is usually acquired by the elderly, is essential
and may spare a patient from surgery or even limb loss, if
early administration of rFVIIa is effective. The course of
disease in a patient with operative management of spon-
taneous bleeding, compartment syndrome and acquired
hemophilia A may be prolonged. However, an interdiscip-
linary approach with meticulous surgical treatment and
bleeding management with rFVIIa, which proved to be ex-
tremely helpful in our patient, especially pre-operatively,
as well as inhibitor eradication by immunosuppressive
treatment can be successful and expensive.
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